Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
333. lappuse
... sterile drugs packaged in com- bination with sterile dispensers , the sample shall be collected by taking 20 dispensers from each sterilizer load , and each dispenser shall be taken from a different part of such sterilizer load . ( 9 ) ...
... sterile drugs packaged in com- bination with sterile dispensers , the sample shall be collected by taking 20 dispensers from each sterilizer load , and each dispenser shall be taken from a different part of such sterilizer load . ( 9 ) ...
353. lappuse
... Sterility requirements of items packaged with sterile antibiotic drugs . ( a ) Diluents packaged in combination with sterile antibiotic drugs . If a sterile antibiotic drug is packaged in com- bination with an immediate container of a ...
... Sterility requirements of items packaged with sterile antibiotic drugs . ( a ) Diluents packaged in combination with sterile antibiotic drugs . If a sterile antibiotic drug is packaged in com- bination with an immediate container of a ...
354. lappuse
... sterilized medium add suffi- cient sterile penicillinase , and proceed as directed for medium B. ( 4 ) Medium D. To each liter of me- dium A add 5.0 milliliters of poly- sorbate 80 and sufficient 2N sodium hy- droxide so that the pH ...
... sterilized medium add suffi- cient sterile penicillinase , and proceed as directed for medium B. ( 4 ) Medium D. To each liter of me- dium A add 5.0 milliliters of poly- sorbate 80 and sufficient 2N sodium hy- droxide so that the pH ...
355. lappuse
... sterile and that has a water - extract pH of 5.5 or greater . De- termine the water - extract pH of a por- tion of the isopropyl myristate as fol- lows : Place 100 milliliters of the iso- propyl myristate sample and 10 milli- liters of ...
... sterile and that has a water - extract pH of 5.5 or greater . De- termine the water - extract pH of a por- tion of the isopropyl myristate as fol- lows : Place 100 milliliters of the iso- propyl myristate sample and 10 milli- liters of ...
356. lappuse
... sterile drug . Using the entire contents from each of 20 immediate containers , proceed as directed in para- graph ( e ) ( 1 ) ( ii ) of this section . ( c ) Sterile dispensers packaged in combination with a sterile drug . Pre- pare 20 ...
... sterile drug . Using the entire contents from each of 20 immediate containers , proceed as directed in para- graph ( e ) ( 1 ) ( ii ) of this section . ( c ) Sterile dispensers packaged in combination with a sterile drug . Pre- pare 20 ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning